2008 Publications Listing

Journal Articles

  1. Ahimastos AA, Dart AM, Kingwell BA. Angiotensin II blockade in Marfan's syndrome. N Engl J Med 2008;359(16):1732.
  2. Ahimastos AA, Dart AM, Lawler A, Blombery PA, Kingwell BA. Reduced arterial stiffness may contribute to angiotensin-converting enzyme inhibitor induced improvements in walking time in peripheral arterial disease patients. J Hypertens 2008;26(5):1037-42.
  3. Ajani AE, Reid CM, Duffy SJ, Andrianopoulos N, Lefkovits J, Black A, New G, Lew R, Shaw JA, Yan BP, Gurvitch R, Al-Fiadh A, Brennan AL, Clark DJ. Outcomes after percutaneous coronary intervention in contemporary Australian practice: insights from a large multicentre registry. Med J Aust 2008;189(8):423-8.
  4. Balasubramaniam R, Kistler PM. AF and heart failure: the chicken or the egg? Heart 2008;Jul 16 [Epub ahead of print].
  5. Ballinger ML, Osman N, Wilks AF, Su S, Burns CJ, Bu X, Little PJ. Pyrido-pyrimidine derivative CYC10424 inhibits glycosaminoglycan changes on vascular smooth muscle-derived proteoglycans and reduces lipoprotein binding. J Cardiovasc Pharmacol 2008;52(5):403-12.
  6. Barton DA, Esler MD, Dawood T, Lambert EA, Haikerwal D, Brenchley C, Socratous F, Hastings J, Guo L, Wiesner G, Kaye DM, Bayles R, Schlaich MP, Lambert GW. Elevated brain serotonin turnover in patients with depression: effect of genotype and therapy. Arch Gen Psychiatr 2008;65(1):38-46.
  7. Baumert M, Lambert GW, Dawood T, Lambert EA, Esler MD, McGrane M, Barton D, Nalivaiko E. QT interval variability and cardiac norepinephrine spillover in patients with depression and panic disorder. Am J Physiol Heart Circ Physiol 2008;295(3):H962-H968.
  8. Bayles RG, Dawood T, Lambert EA, Schlaich MP, Lambert GW. Elevated cardiac risk in patients with major depressive disorder. Am J Psychiatry 2008;165(1):137.
  9. Bayliss J, Maguire JA, Bailey M, Leet A, Kaye D, Richardson M, Bergin PJ, Dowling J, Thomson NM, Stein AN. Increased vascular endothelial growth factor mRNA in endomyocardial biopsies from allografts demonstrating severe acute rejection: a
  10. Byrne M, Kaye DM, Power J. The synergism between atrial fibrillation and heart failure. J Card Fail 2008;14(4):320-6.
  11. Byrne MJ, Power JM, Preovolos A, Mariani JA, Hajjar RJ, Kaye DM. Recirculating cardiac delivery of AAV2/1SERCA2a improves myocardial function in an experimental model of heart failure in large animals. Gene Ther 2008;15(23):1550-7.
  12. Camuglia A, Manins V, Taylor A, Hengel C. Case report and review: epicardial coronary artery fibromuscular dysplasia. Heart Lung Circ 2008;Jan 30 [Epub ahead of print].
  13. Chung J, Nguyen AK, Henstridge DC, Holmes AG, Chan MH, Mesa JL, Lancaster GI, Southgate RJ, Bruce CR, Duffy SJ, Horvath I, Mestril R, Watt MJ, Hooper PL, Kingwell BA, Vigh L, Hevener A, Febbraio MA. HSP72 protects against obesity-induced insulin resistance. Proc Natl Acad Sci USA 2008;105(5):1739-44.
  14. Dart AM, Cameron JD, Gatzka C, Kingwell BA, Jennings GLR. Letter. Response to effects of angiotensin-converting enzyme inhibitors on central blood pressure. Hypertension 2008;50(3):e64.
  15. Dart AM, Kingwell BA, Gatzka CD, Willson K, Liang YL, Berry KL, Wing LM, Reid CM, Ryan P, Beilin LJ, Jennings GL, Johnston CI, McNeil JJ, MacDonald GJ, Morgan TO, West MJ, Cameron JD. Smaller aortic dimensions do not fully account for the greater pulse pressure in elderly female hypertensives. Hypertension 2008;51(4):1129-34.
  16. Duffy SJ, Dart AM. Novel cardiac therapies and innocent by standers. Lancet 2008;371(9626):1726-8.
  17. Esler M, Eikelis N, Schlaich M, Lambert G, Alvarenga M, Dawood T, Kaye D, Barton D, Pier C, Guo L, Brenchley C, Jennings G, Lambert E. Chronic mental stress is a cause of essential hypertension: presence of biological markers of stress. Clin Exp Pharmacol Physiol 2008;35(4):498-502.
  18. Esler MD, Eikelis N, Lambert E, Straznicky N. Neural mechanisms and management of obesity-related hypertension. Curr Cardiol Rep 2008;10(6):456-63.
  19. Fang L, Gao XM, Samuel CS, Su Y, Lim YL, Dart AM, Du XJ. Higher levels of collagen and facilitated healing protect against ventricular rupture following myocardial infarction. Clin Sci 2008;115(3):99-106.
  20. Friedrich MG, Abdel-Aty H, Taylor A, Schulz-Menger J, Messroghli D, Dietz R. The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. J Am Coll Cardiol 2008;51(16):1581-7.
  21. Gould PA, Esler MD, Kaye DM. Atrial fibrillation is associated with decreased cardiac sympathetic response to isometric exercise in CHF in comparison to sinus
  22. Haqqani HM, Kalman JM, Kistler PM. Catheter ablation for atrial fibrillation: have we come the full circle? J Cardiovasc Electrophysiol 2008;19(5):480-2.
  23. Hoang A, Tefft C, Duffy SJ, Formosa M, Henstridge DC, Kingwell BA, Sviridov D. ABCA1 expression in humans is associated with physical activity and alcohol consumption. Atherosclerosis 2008;197(1):197-203.
  24. Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, Kaye DM, Taylor AJ. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol 2008;52(19):1574-80.
  25. Kaye DM, Esler MD. Autonomic control of the aging heart. Neuromolecular Med 2008;10(3):179-86.
  26. Kaye DM, Esler MD. Re: Cardiac denervation does/does not play a major role in exercise limitation after heart transplantation. J Appl Physiol 2008;104(2):567.
  27. Kaye DM, Hoshijima M, Chien KR. Reversing advanced heart failure by targeting Ca2+ cycling. Annu Rev Med 2008;59:13-28.
  28. Kiriazis H, Wang K, Xu Q, Gao XM, Ming Z, Su Y, Moore XL, Lambert G, Gibbs ME, Dart AM, Du XJ. Knockout of β(1)- and β(2)-adrenoceptors attenuates pressure overload-induced cardiac hypertrophy and fibrosis. Br J Pharmacol 2008;153(4):684-92.
  29. Kistler PM. Multi electrode ablation for paroxysmal atrial fibrillation: Pulmonary vein isolation made easy? Heart Rhythm 2008;5(12):1643-44.
  30. Kistler PM, Rajappan K, Harris S, Earley MJ, Richmond L, Sporton SC, Schilling RJ. Impact of image integration on catheter ablation of atrial fibrillation using electroanatomic mapping: a prospective randomized study. Eur Heart J 2008;29(24):3029-36.
  31. Lambert E, Dawood T, Schlaich M, Straznicky N, Esler M, Lambert G. Single-unit sympathetic discharge pattern in pathological conditions associated with elevated cardiovascular risk. Clin Exp Pharmacol Physiol 2008;35(4):503-7.
  32. Lambert E, Eikelis N, Esler M, Dawood T, Schlaich M, Bayles R, Socratous F, Agrotis A, Jennings G, Lambert G, Vaddadi G. Altered sympathetic nervous reactivity and norepinephrine transporter expression in patients with the postural tachycardia syndrome. Circ Arrhythmia Electrophysiol 2008;1:103-109.
  33. Maeder MT, Holst DP, Kaye DM. Tricuspid regurgitation contributes to renal dysfunction in patients with heart failure. J Card Fail 2008;14(10):824-30.
  34. Maeder MT, Kaye DM. B-type natriuretic peptide in end-stage renal disease: a neurohormone rather than a volume status monitor. South Med J 2008;101(11):1081-2.
  35. Masuo K, Lambert GW, Esler MD. Does epinephrine cause hypertension? - Epinephrine hypothesis. In: Lawson AG, Gorman RI (eds). Research Progress on Epinephrine, Nova Science Publishers, New York 2008;Chapter 5:95-114.
  36. Masuo K, Lambert GW, Rakugi H, Ogihara T, Esler MD. Neurovascular role of sympathetic nervous system and β- adrenoceptor polymorphisms in obesity and hypertension. Curr Hypertens Rev 2008;4(2):121-30.
  37. Masuo K, Straznicky N, Esler MD. Obesity and obesity-related hypertension: role of the sympathetic nervous system and β-adrenoreceptor polymorphisms. In: Kaneko M (ed) Sympathetic Nervous System Research Developments, Nova Science Publishers, USA 2008;Chapter 2:67-92.
  38. Masuo K, Straznicky NE, Lambert GW, Katsuya T, Sugimoto K, Rakugi H, Socratous F, Hastings J, Lambert EA, Ogihara T, Esler MD. Leptin-receptor polymorphisms relate to obesity through blunted leptin-mediated sympathetic nerve activation in a Caucasian male population. Hypertens Res 2008;31(6):1093-100.
  39. Pfluger HB, Phrommintikul A, Mariani JA, Cherayath JG, Taylor AJ. Utility of myocardial fibrosis and fatty infiltration detected by cardiac magnetic resonance imaging in the diagnosis of arrhythmogenic right ventricular dysplasia-a single centre experience. Heart Lung Circ 2008;17(6):478-83.
  40. Roberts-Thomson KC, Stevenson IH, Kistler PM, Haqqani HM, Goldblatt JC, Sanders P, Kalman JM. Anatomically determined functional conduction delay in the posterior left atrium relationship to structural heart disease. J Am Coll Cardiol 2008;51(8):856-62.
  41. Rose H, Hoy J, Woolley I, Tchoua U, Bukrinsky M, Dart A, Sviridov D. HIV infection and high density lipoprotein metabolism. Atherosclerosis 2008;199(1):79-86.
  42. Shaw JA, Andrianopoulos N, Duffy S, Walton AS, Clark D, Lew R, Sebastian M, New G, Brennan A, Reid C, Ajani AE; On behalf of the Melbourne Interventional Group. Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stents. Cardiovasc Revasc Med 2008;9(4):218-223.
  43. Shaw JA, Bobik A, Murphy A, Kanellakis P, Blombery P, Mukhamedova N, Woollard K, Lyon S, Sviridov D, Dart AM. Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque. Circ Res 2008;103(10):1084-91.
  44. Sicree RA, Zimmet PZ, Dunstan DW, Cameron AJ, Welborn TA, Shaw JE. Differences in height explain gender differences in the response to the oral glucose tolerance test- the AusDiab study. Diabet Med 2008;25(3):296-302.
  45. Skilton MR. Intrauterine risk factors for precocious atherosclerosis. Pediatrics 2008;121(3):570-4.
  46. Skilton MR, Laville M, Cust AE, Moulin P, Bonnet F. The association between dietary macronutrient intake and the prevalence of the metabolic syndrome. Br J Nutr 2008;100(2):400-7.
  47. Skilton MR, Sieveking DP, Harmer JA, Franklin J, Loughnan G, Nakhla S, Sullivan DR, Caterson ID, Celermajer DS. The effects of obesity and non-pharmacological weight loss on vascular and ventricular function and structure. Diabetes Obes Metab 2008;10(10):874-84.
  48. Sliwa K, Wilkinson D, Hansen C, Ntyintyane L, Tibazarwa K, Becker A, Stewart S. Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study. Lancet 2008;371(9616):915-22.
  49. Stewart S. Beyond the numbers: the individual challenges of combating consistently poor survival in heart failure. Am Heart J 2008;155(2):195-6.
  50. Stewart S, Wilkinson D, Hansen C, Vaghela V, Mvungi R, McMurray J, Sliwa K. Predominance of heart failure in the Heart of Soweto Study Cohort. Emerging challenges for urban African communities. Circulation 2008;118(23):2360-7.
  51. Straub A, Wendel HP, Dietz K, Schiebold D, Peter K, Schoenwaelder SM, Ziemer G. Selective inhibition of the platelet phosphoinositide 3-kinase p110β as promising new strategy for platelet protection during extracorporeal circulation. Thromb Haemost 2008;99(3):609-15.
  52. Straznicky NE, Eikelis N, Lambert EA, Esler MD. Mediators of sympathetic activation in metabolic syndrome obesity. Curr Hypertens Rep 2008;10(6):440-7.
  53. Straznicky NE, Nestel PJ, Esler MD. Autonomic nervous control of metabolic function. In: Squire LR (ed) Encyclopaedia of Neuroscience. Elsevier, Academic Press 2008.
  54. Sviridov D, Hoang A, Ooi E, Watts G, Barrett PH, Nestel P. Indices of reverse cholesterol transport in subjects with metabolic syndrome after treatment with rosuvastatin. Atherosclerosis 2008;197(2):732-9.
  55. Sviridov D, Mukhamedova N, Remaley AT, Chin-Dusting J, Nestel P. Antiatherogenic functionality of high density lipoprotein: how much versus how good. J Atheroscler Thromb 2008;15(2):52-62.
  56. Sviridov D, Nestel P, Watts G. Statins and metabolism of high density lipoprotein. Cardiovasc Hematol Agents Med Chem 2008;5(3):215-21.
  57. Szollosi I, Thompson BR, Krum H, Kaye DM, Naughton MT. Impaired pulmonary diffusing capacity and hypoxia in heart failure correlates with central sleep apnea severity. Chest 2008;134(1):67-72.
  58. Tan MA, Dean CJ, Hopwood JJ, Meikle PJ. Diagnosis of metachromatic leukodystrophy by immune quantification of arylsulphatase A protein and activity in dried blood spots. Clin Chem 2008;54(11):1925-7.
  59. Woodcock EA, Kistler PM, Ju Y. Phosphoinositide signalling and cardiac arrhythmias. Cardiovasc Res 2008;Nov 11 [Epub ahead of print].
  60. Woollard KJ, Suhartoyo A, Harris EE, Eisenhardt SU, Jackson SP, Peter K, Dart AM, Hickey MJ, Chin-Dusting JP. Pathophysiological levels of soluble P-selectin mediate adhesion of leukocytes to the endothelium through Mac-1 activation. Circ Res 2008;103(10):1128-38.
  61. Xu Q, Lekgabe ED, Gao XM, Ming Z, Tregear GW, Dart AM, Bathgate RA, Samuel CS, Du XJ. Endogenous relaxin does not affect chronic pressure overload-induced cardiac hypertrophy and fibrosis. Endocrinology 2008;149(2):476-82.
  62. Yan BP, Ajani AE, New G, Duffy SJ, Farouque O, Shaw J, Sebastian M, Lew R, Brennan A, Andrianopoulos N, Reid C, Clark DJ; Melbourne Interventional Group Investigators. Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registry. Int J Cardiol 2008;130(3):374-9.
  63. Yan BP, Duffy SJ, Clark DJ, Lefkovits J, Warren R, Gurvitch R, Lew R, Sebastian M, Brennan A, Andrianopoulos N, Reid CM, Ajani AE; Melbourne Interventional Group. Rates of stent thrombosis in bare-metal versus drug-eluting stents (from a large Australian multicenter registry). Am J Cardiol 2008;101(12):1716-22.
  64. Zhang WZ, Venardos K, Finch S, Kaye DM. Detrimental effect of oxidized LDL on endothelial arginine metabolism and transportation. Int J Biochem Cell Biol 2008;40(5):920-8.



Consultation in the Heart Centre is only by referral from a Medical Practitioner.



Please follow the link to find further information



‘This just doesn’t happen to people like me.’  aged 50...

Support US


Donate or Volunteer for research study. See how you can help.

Copyright © Alferd Health Victoria 2013 | Login